180 related articles for article (PubMed ID: 16459633)
61. Practical use of capecitabine plus oxaliplatin (CAPEOX) with bevacizumab for patients with metastatic colorectal cancer that cannot expect conversion therapy.
Yokomizo H; Yoshimatsu K; Otani T; Osawa G; Nakayama M; Matsumoto A; Yano Y; Okayama S; Naritaka Y
Hepatogastroenterology; 2013; 60(128):1911-5. PubMed ID: 24719926
[TBL] [Abstract][Full Text] [Related]
62. [Combined surgical and oncological management of colorectal liver metastases].
Bergenfeldt M; Jensen BV
Ugeskr Laeger; 2008 Apr; 170(16):1353-6. PubMed ID: 18433598
[TBL] [Abstract][Full Text] [Related]
63. [Specific treatment situations in metastatic colorectal cancer].
Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
[TBL] [Abstract][Full Text] [Related]
64. Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes.
Gervaz P; Rubbia-Brandt L; Andres A; Majno P; Roth A; Morel P; Mentha G
Ann Surg Oncol; 2010 Oct; 17(10):2714-9. PubMed ID: 20405223
[TBL] [Abstract][Full Text] [Related]
65. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases.
Fernandez FG; Ritter J; Goodwin JW; Linehan DC; Hawkins WG; Strasberg SM
J Am Coll Surg; 2005 Jun; 200(6):845-53. PubMed ID: 15922194
[TBL] [Abstract][Full Text] [Related]
66. Chemotherapy Plus Bevacizumab as Neoadjuvant or Conversion Treatment in Patients with Colorectal Liver Metastases.
García-Alfonso P; Cavanagh Podesta M; Muñoz Martín A; Blanco Codeisido M; Calvo A; Peligros I; Corcuera A; Belén Rúperez Blanco A; Custodio-Cabello S; López Trabada D; Martín M; DE Ramón E
Anticancer Res; 2018 May; 38(5):3069-3077. PubMed ID: 29715142
[TBL] [Abstract][Full Text] [Related]
67. Impact of novel histopathological factors on the outcomes of liver surgery for colorectal cancer metastases.
Serrablo A; Paliogiannis P; Pulighe F; Moro SS; Borrego-Estella V; Attene F; Scognamillo F; Hörndler C
Eur J Surg Oncol; 2016 Sep; 42(9):1268-77. PubMed ID: 26947960
[TBL] [Abstract][Full Text] [Related]
68. Impact of neoadjuvant chemotherapy on short-term outcomes after simple and complex minimally invasive minor hepatectomy for colorectal liver metastases: A propensity-score matched and coarsened exact matched study.
Hoogteijling TJ; Abu Hilal M; Zimmitti G; Aghayan DL; Wu AGR; Cipriani F; Gruttadauria S; Scatton O; Long TCD; Herman P; Marino MV; Mazzaferro V; Chiow AKH; Sucandy I; Ivanecz A; Choi SH; Lee JH; Gastaca M; Vivarelli M; Giuliante F; Ruzzenente A; Yong CC; Yin M; Fondevila C; Efanov M; Morise Z; Di Benedetto F; Brustia R; Dalla Valle R; Boggi U; Geller D; Belli A; Memeo R; Mejia A; Park JO; Rotellar F; Choi GH; Robles-Campos R; Wang X; Sutcliffe RP; Pratschke J; Tang CN; Chong CCN; D'Hondt M; Monden K; Lopez-Ben S; Kingham TP; Ferrero A; Ettorre GM; Cherqui D; Liang X; Soubrane O; Wakabayashi G; Troisi RI; Han HS; Cheung TT; Sugioka A; Dokmak S; Chen KH; Liu R; Fuks D; Zhang W; Aldrighetti L; Edwin B; Goh BKP;
Eur J Surg Oncol; 2024 Jun; 50(6):108309. PubMed ID: 38626588
[TBL] [Abstract][Full Text] [Related]
69. Neoadjuvant chemotherapy in the management of colorectal metastases: A review of the literature.
Ong SY
Ann Acad Med Singap; 2003 Mar; 32(2):205-11. PubMed ID: 12772524
[TBL] [Abstract][Full Text] [Related]
70. Hepatectomy for Colorectal Cancer Liver Metastases in the Era of Modern Preoperative Chemotherapy: Evaluation of Postoperative Complications.
Fukuoka K; Nara S; Honma Y; Kishi Y; Esaki M; Shimada K
World J Surg; 2017 Apr; 41(4):1073-1081. PubMed ID: 27679508
[TBL] [Abstract][Full Text] [Related]
71. Safety evaluation of simultaneous resection of colorectal primary tumor and liver metastasis after neoadjuvant therapy: A propensity score matching analysis.
Wu Y; Liu F; Song W; Liang F; Wang L; Xu Y
Am J Surg; 2019 Nov; 218(5):894-898. PubMed ID: 30268420
[TBL] [Abstract][Full Text] [Related]
72. [Liver metastases--primary or multimodal therapy?].
Ott R; Wein A; Hohenberger W
Chirurg; 2001 Aug; 72(8):887-97. PubMed ID: 11554132
[TBL] [Abstract][Full Text] [Related]
73. LiMAx Test Improves Diagnosis of Chemotherapy-Associated Liver Injury Before Resection of Colorectal Liver Metastases.
Lock JF; Westphal T; Rubin T; Malinowski M; Schulz A; Jara M; Bednarsch J; Stockmann M
Ann Surg Oncol; 2017 Sep; 24(9):2447-2455. PubMed ID: 28516292
[TBL] [Abstract][Full Text] [Related]
74. Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases.
Chua TC; Saxena A; Liauw W; Kokandi A; Morris DL
Ann Surg Oncol; 2010 Feb; 17(2):492-501. PubMed ID: 19856028
[TBL] [Abstract][Full Text] [Related]
75. Impact of perioperative chemotherapy on survival outcomes among patients with metastatic colorectal cancer to the liver.
Baidoun F; Merjaneh Z; Nanah R; Saad AM; Abdel-Rahman O
J Comp Eff Res; 2022 Sep; 11(13):935-951. PubMed ID: 35787069
[No Abstract] [Full Text] [Related]
76. [A case of hypersensitivity reaction to reintroduced-oxaliplatin at the second course of oxaliplatin-based chemotherapy after neoadjuvant chemotherapy for liver metastases from colon cancer].
Katayose Y; Nakagawa K; Onogawa T; Yoshida H; Motoi F; Naitoh T; Rikiyama T; Egawa S; Unno M
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2651-3. PubMed ID: 22189236
[TBL] [Abstract][Full Text] [Related]
77. Impact of chemotherapy-associated liver injury on tumour regression grade and survival in patients with colorectal liver metastases.
Zhao J; Sawo P; Rensen SS; Rouflart MMJ; Winstanley A; Vreuls CPH; Verheij J; van Mierlo KMC; Lodewick TM; van Woerden V; van Tiel FH; van Dam RM; Dejong CHC; Olde Damink SWM
HPB (Oxford); 2018 Feb; 20(2):147-154. PubMed ID: 28969959
[TBL] [Abstract][Full Text] [Related]
78. Augmented Reality Guidance for the Resection of Missing Colorectal Liver Metastases: An Initial Experience.
Ntourakis D; Memeo R; Soler L; Marescaux J; Mutter D; Pessaux P
World J Surg; 2016 Feb; 40(2):419-26. PubMed ID: 26316112
[TBL] [Abstract][Full Text] [Related]
79. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel.
Nordlinger B; Van Cutsem E; Gruenberger T; Glimelius B; Poston G; Rougier P; Sobrero A; Ychou M; ;
Ann Oncol; 2009 Jun; 20(6):985-92. PubMed ID: 19153115
[TBL] [Abstract][Full Text] [Related]
80. Limiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastases.
Sturesson C; Nilsson J; Eriksson S; Spelt L; Andersson R
HPB (Oxford); 2013 Aug; 15(8):646-52. PubMed ID: 23458360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
